Evidence map›Paper›PMID 36411273›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2023

Peripheral Blood DNA Methylation-Based Machine Learning Models for Prediction of Knee Osteoarthritis Progression: Biologic Specimens and Data From the Osteoarthritis Initiative and Johnston County Osteoarthritis Project.

Christopher M Dunn, Cassandra Sturdy, Cassandra Velasco, Leoni Schlupp, Emmaline Prinz, Vladislav Izda, Liubov Arbeeva, Yvonne M Golightly, Amanda E Nelson, Matlock A Jeffries

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Christopher M DunnDivision of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, University of Oklahoma Health Sciences Center, and Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City.ORCID 0000-0002-8611-7271
Cassandra SturdyArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City.ORCID 0000-0002-7733-6747
Cassandra VelascoDivision of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, University of Oklahoma Health Sciences Center, and Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City.
Leoni SchluppArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City.ORCID 0000-0002-2837-5942
Emmaline PrinzArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City.ORCID 0000-0001-8497-6171
Vladislav IzdaIcahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0002-7561-2699
Liubov ArbeevaThurston Arthritis Research Center, University of North Carolina at Chapel Hill.ORCID 0000-0001-5004-419X
Yvonne M GolightlyCollege of Allied Health Professions, University of Nebraska Medical Center, Omaha.ORCID 0000-0003-1205-2759
Amanda E NelsonThurston Arthritis Research Center, University of North Carolina at Chapel Hill.ORCID 0000-0002-9344-7877
Matlock A JeffriesDivision of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, University of Oklahoma Health Sciences Center, and Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City.ORCID 0000-0001-9516-4312
Oklahoma Medical Research Foundation · USUniversity of North Carolina at Chapel Hill · USIcahn School of Medicine at Mount Sinai · US

Funding

Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Marisol Castillo-Castrejon · 2019 to 2026
$17.8M
UNC Core Center for Clinical ResearchP30AR072580 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEIGH Fleming CALLAHAN, Amanda E Nelson · 2019 to 2026
$6.1M
Project 3P60AR049465 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JORDAN, JOANNE M. · 2003 to 2008
$6.0M
NIAMS Multidisciplinary Clinical Research CenterP60AR064166 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CALLAHAN, LEIGH FLEMING · 2013 to 2017
$5.8M
Johnston County Osteoarthritis Project: Arthritis, Disability, and Other Chronic DiseasesU01DP006266 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NELSON, AMANDA E · 2016 to 2020
$3.8M
Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression.R01AR076440 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BHUTANI, NIDHI, JEFFRIES, MATLOCK · 2020 to 2025
$3.6M
The Johnston County OA Project: Arthritis and DisabilityU01DP003206 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JORDAN, JOANNE M. · 2011 to 2015
$3.2M
Women's knee motion patterns in functional activitiesP60AR030701 · NIAMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI WINFIELD, JOHN B · 1986 to 2001
$1.9M
An integrative study of circulating leukocyte composition, epigenetic patterns, and functional consequences in knee osteoarthritis.K08AR070891 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JEFFRIES, MATLOCK · 2017 to 2021
$862k
Intraarticular microbial DNA as a novel mediator of osteoarthritisR61AR078075 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JEFFRIES, MATLOCK · 2020 to 2021
$861k
Intraarticular microbial DNA as a novel mediator of osteoarthritisR33AR078075 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JEFFRIES, MATLOCK · 2022 to 2022
$437k
ACL HHS U01DP003206ACL HHS U01DP006266NCCDPHP CDC HHS U01 DP003206NCCDPHP CDC HHS U01 DP006266NIAMS NIH HHS K08 AR070891NIAMS NIH HHS P30 AR072580NIAMS NIH HHS P60 AR030701NIAMS NIH HHS P60 AR049465NIAMS NIH HHS P60 AR064166NIAMS NIH HHS R01 AR076440NIAMS NIH HHS R33 AR078075NIAMS NIH HHS R61 AR078075NIGMS NIH HHS P20 GM125528NIGMS NIH HHS P20GM125528
6 · The paper itself

Abstract

objectiveThe lack of accurate biomarkers to predict knee osteoarthritis (OA) progression is a key unmet need in OA clinical research. The objective of this study was to develop baseline peripheral blood epigenetic biomarker models to predict knee OA progression.

methodsGenome-wide buffy coat DNA methylation patterns from 554 individuals from the Osteoarthritis Biomarkers Consortium (OABC) were determined using Illumina Infinium MethylationEPIC 850K arrays. Data were divided into model development and validation sets, and machine learning models were trained to classify future OA progression by knee pain, radiographic imaging, knee pain plus radiographic imaging, and any progression (pain, radiographic, or both). Parsimonious models using the top 13 CpG sites most frequently selected during development were tested on independent samples from participants in the Johnston County Osteoarthritis (JoCo OA) Project (n = 128) and a previously published Osteoarthritis Initiative (OAI) data set (n = 55).

resultsFull models accurately classified future radiographic-only progression (mean ± SEM accuracy 87 ± 0.8%, area under the curve [AUC] 0.94 ± 0.004), pain-only progression (accuracy 89 ± 0.9%, AUC 0.97 ± 0.004), pain plus radiographic progression (accuracy 72 ± 0.7%, AUC 0.79 ± 0.006), and any progression (accuracy 78 ± 0.4%, AUC 0.86 ± 0.004). Pain-only and radiographic-only progressors were not distinguishable (mean ± SEM accuracy 58 ± 1%, AUC 0.62 ± 0.001). Parsimonious models showed similar performance and accurately classified future radiographic progressors in the OABC cohort and in both validation cohorts (mean ± SEM accuracy 80 ± 0.3%, AUC 0.88 ± 0.003 [using JoCo OA Project data], accuracy 80 ± 0.8%, AUC 0.89 ± 0.002 [using previous OAI data]).

conclusionOur data suggest that pain and structural progression share similar early systemic immune epigenotypes. Further studies should focus on evaluating the pathophysiologic consequences of differential DNA methylation and peripheral blood cell epigenotypes in individuals with knee OA.

Indexed as

Biological ProductsOsteoarthritis, KneeBiomarkersDisease ProgressionDNA MethylationHumansKnee JointPainBiological ProductsBiomarkers

Identifiers

PMID36411273
PMCPMC9797424
OpenAlexW4291149665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.